New method for estimating HIV incidence and time from infection to diagnosis using HIV surveillance data: Results for France

AIDS

Volumn 25, Issue 15, 2011, Pages 1905-1913

  Ndawinz, Jacques D A ^a,b   Costagliola, Dominique ^a,b,c   Supervie, Virginie ^a,b  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

AIDS; epidemiology; France; incidence of HIV; mathematical model; surveillance; testing policy; time between HIV infection and diagnosis

Indexed keywords

ADULT; ARTICLE; DISEASE DURATION; FEMALE; FRANCE; HEALTH SURVEY; HETEROSEXUAL FEMALE; HETEROSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PRIORITY JOURNAL;

ADULT; ANTI-HIV AGENTS; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; EARLY DIAGNOSIS; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE;

EID: 80052924368     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834af619     Document Type: Article

References (35)

1. Anglemyer A, Rutherford GW, Egger M, Siegfried N. Antire-troviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev 2011: CD009153.
2. Cain LE, Logan R, Robins JM, Sterne JA, Sabin C, Bansi L, et al. When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. Ann Intern Med 2011; 154:509-515.
3. Walensky RP, Paltiel AD, Losina E, Morris BL, Scott CA, Rhode ER, et al. Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Infect Dis 2010; 51:392-400.
4. Anonymous. Initiation of antiretroviral treatment protects unin-fected sexual partners from HIV infection (HPTN Study 052). 2011.
5. Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 2010; 304:321-333.
6. Archibald CP, Alexander P, Gatali M, Geduld J. Undiagnosed HIV infections: the rate limiting step for the 3 by 5 initiative. International Conference on AIDS; Bangkok, Thailand; 2004.
7. Hamers FF, Phillips AN. Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med 2008; 9 (Suppl 2): 6-12. (Pubitemid 351819089)
8. Campsmith ML, Rhodes PH, Hall HI, Green TA. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr 2010; 53:619-624.
9. Bartlett JG, Branson BM, Fenton K, Hauschild BC, Miller V, Mayer KH. Opt-out testing for human immunodeficiency virus in the United States: progress and challenges. JAMA 2008; 300:945-951.
10. Martin EG, Paltiel AD, Walensky RP, Schackman BR. Expanded HIV screening in the United States: what will it cost government discretionary and entitlement programs? A budget impact analysis. Value Health 2010; 13:893-902.
11. Mounier-Jack S, Nielsen S, Coker RJ. HIV testing strategies across European countries. HIV Med 2008; 9 (Suppl 2): 13-19. (Pubitemid 351819090)
12. Dodds C, Weatherburn P. Reducing the length of time between HIV infection and diagnosis. BMJ 2007; 334:1329-1330. (Pubitemid 47041250)
13. Brookmeyer R. Measuring the HIV/AIDS epidemic: approaches and challenges. Epidemiol Rev 2010; 32:26-37.
14. Karon JM, Song R, Brookmeyer R, Kaplan EH, Hall HI. Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results. Stat Med 2008; 27:4617-4633.
15. Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, et al. Estimation of HIV incidence in the United States. JAMA 2008; 300:520-529.
16. EuroHIV. Report on the EuroHIV 2006 survey on HIV and AIDS surveillance in the WHO European Region. Saint-Maurice: In-stitut de Veille Sanitaire; 2007.
17. Downs AM, Heisterkamp SH, Brunet JB, Hamers FF. Reconstruction and prediction of the HIV/AIDS epidemic among adults in the European Union and in the low prevalence countries of central and eastern Europe. AIDS 1997; 11:649-662. (Pubitemid 27135887)
18. Rude N, Costagliola D, Valleron AJ. Cumulative incidence of HIV infection and AIDS case prediction in France. Lancet 1993; 342:436-437. (Pubitemid 23236372)
19. Becker NG, Lewis JJ, Li Z, McDonald A. Age-specific back-projection of HIV diagnosis data. Stat Med 2003; 22:2177-2190. (Pubitemid 36818043)
20. Sweeting MJ, De Angelis D, Aalen OO. Bayesian back-calculation using a multistate model with application to HIV. Stat Med 2005; 24:3991-4007. (Pubitemid 43115743)
21. Devaux I, Alix J, Likatavicius G, Herida M, Nielsen SS, Hamers FF, Nardone A. Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) case reporting in the World Health Organization European Region in 2006. Euro Surveill 2008; 13.
22. Semaille C, Cazein F, Pillonel J, Lot F, Le Vu S, Pinget R, et al. Four years of surveillance of recent HIV infections at country level, France, mid 2003-2006: experience and perspectives. Euro Surveill 2008; 13.
23. Berglund PA. An introduction to multiple imputation of complex sample data using SAS1 v9.2. 2010.
24. Hollingsworth TD, Anderson RM, Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis 2008; 198:687-693.
25. Brookmeyer R, Goedert JJ. Censoring in an epidemic with an application to hemophilia-associated AIDS. Biometrics 1989; 45:325-335. (Pubitemid 19109177)
26. Lodi S, Phillips A, Touloumi G, Geskus R, Meyer L, Thiébaut R, et al. Proportion of individuals likely to need treatment for CD4 thresholds <200, <350, and <500 cells/mL. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, 2010.
27. Cazein F, Pillonel J, Bousquet V, Imounga L, Le Vu S, le Strat Y, et al. Determinants of persons diagnosed with HIV or AIDS, France, 2008. BEH Web 2009; 2:1-15.
28. Delpierre C, Cuzin L, Lert F. Routine testing to reduce late HIV diagnosis in France. BMJ 2007; 334:1354-1356. (Pubitemid 47041265)
29. Anonymous. Premiers resultat de l'Enquete Presse Gay. 2004. Saint-Maurice: Institut de Veille Sanitaire 2005.
30. Anonymous. Bulletin des reseaux de surveillance des infections sexuellement transmissibles au 31 decembre 2008-Rénago, Renachla et ResIST. Saint-Maurice: Institut de Veille Sanitaire, 2010.
31. Le Vu S, Le Strat Y, Barin F, Pillonel J, Cazein F, Bousquet V, et al. Population-based HIV-1 incidence in France, 2003-08: a modelling analysis. Lancet Infect Dis 2010; 10:682-687.
32. Regnard C. Immigration et presence etrangere en France en 2006: Rapport annuel de la direction de la population et des migrations. La Documentation Francaise; 2008.
33. UNAIDS. Report on the global AIDS epidemic. 2008.
34. Le Vu S, Meyer L, Cazein F, Pillonel J, Semaille C, Barin F, Desenclos JC. Performance of an immunoassay at detecting recent infection among reported HIV diagnoses. AIDS 2009; 23:1773-1779.
35. Sakarovitch C, Rouet F, Murphy G, Minga AK, Alioum A, Dabis F, et al. Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa? J Acquir Immune Defic Syndr 2007; 45:115-122. (Pubitemid 46684451)